Debra J. Bruzek

1.8k total citations · 1 hit paper
34 papers, 1.4k citations indexed

About

Debra J. Bruzek is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Debra J. Bruzek has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Debra J. Bruzek's work include Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Molecular Biology Techniques and Applications (6 papers). Debra J. Bruzek is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Molecular Biology Techniques and Applications (6 papers). Debra J. Bruzek collaborates with scholars based in United States, Sweden and United Kingdom. Debra J. Bruzek's co-authors include Patrick C. Walsh, Daniel W. Chan, Robert C. Rock, Joseph E. Oesterling, Jonathan I. Epstein, Allyn W. Kimball, Charles B. Brendler, Alan W. Partin, Lori J. Sokoll and Daniel W. Chan and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Clinical Chemistry.

In The Last Decade

Debra J. Bruzek

34 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy

1988 477 citations Joseph E. Oesterling, Daniel W. Chan et al. The Journal of Urology profile →

Peers

Countries citing papers authored by Debra J. Bruzek

Since Specialization

Citations

This map shows the geographic impact of Debra J. Bruzek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra J. Bruzek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra J. Bruzek more than expected).

Fields of papers citing papers by Debra J. Bruzek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra J. Bruzek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra J. Bruzek. The network helps show where Debra J. Bruzek may publish in the future.

Co-authorship network of co-authors of Debra J. Bruzek

This figure shows the co-authorship network connecting the top 25 collaborators of Debra J. Bruzek. A scholar is included among the top collaborators of Debra J. Bruzek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra J. Bruzek. Debra J. Bruzek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PROSTATE INVOLVEMENT DURING SEXUALLY TRANSMITTED INFECTIONS AS MEASURED BY PROSTATE SPECIFIC ANTIGEN CONCENTRATION 2009 ·The Journal of Urology ·Siobhan Sutcliffe, Remington L. Nevin, Ratna Pakpahan, Debra J. Bruzek, Stephen R. Cole, Angelo M. De Marzo, Charlotte A. Gaydos, William B. Isaacs, William G. Nelson, Lori J. Sokoll, Jonathan M. Zenilman, Steven B. Cersovsky, Elizabeth A. Platz	1
2	Complexed prostate‐specific antigen for the diagnosis of biochemical recurrence after radical prostatectomy 2007 ·British Journal of Urology ·J. Kellogg Parsons, Alan W. Partin, Bruce J. Trock, Debra J. Bruzek, Carol D Cheli, Lori J. Sokoll	10
3	ASSOCIATION BETWEEN SERUM ADIPONECTIN, AND PATHOLOGICAL STAGE AND GRADE IN MEN UNDERGOING RADICAL PROSTATECTOMY 2005 ·The Journal of Urology ·Stephen J. Freedland, Lori J. Sokoll, Elizabeth A. Platz, Leslie A. Mangold, Debra J. Bruzek, (unknown), (unknown), Alan W. Partin	56
4	957: Validity of Complexed Prostate Specific Antigen (CPSA) for the Diagnosis of Biochemical Recurrence after Radical Retropubic Prostatectomy 2005 ·The Journal of Urology ·J. Kellogg Parsons, Lori J. Sokoll, Bruce J. Trock, Debra J. Bruzek, Carol D Cheli, Alan W. Partin	1
5	1659: Effects of Finasteride and Saw Palmetto on BPSA, Propsa, and cPSA in Men with Benign Prostatic Hyperplasia 2004 ·The Journal of Urology ·Lori J. Sokoll, Leonard S. Marks, Stephen D. Mikolajczyk, Debra J. Bruzek, (unknown), Leslie A. Mangold, Harry G. Rittenhouse, Daniel W. Chan, Alan W. Partin	1
6	Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models 2003 ·The Prostate ·Samuel R. Denmeade, Lori J. Sokoll, Susan L. Dalrymple, Dina Rosen, (unknown), Debra J. Bruzek, Rebecca M. Ricklis, John T. Isaacs	111
7	Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men 2002 ·Urology ·Lori J. Sokoll, Leslie A. Mangold, Alan W. Partin, Jonathan I. Epstein, Debra J. Bruzek, (unknown), (unknown), (unknown), Daniel W. Chan	12
8	Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios in discriminating between benign prostatic hyperplasia and prostate cancer 2002 ·Clinica Chimica Acta ·Frank H. Wians, Carol D Cheli, Jody Balko, Debra J. Bruzek, Daniel W. Chan, Lori J. Sokoll	6
9	Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen 2002 ·Urology ·Lori J. Sokoll, Debra J. Bruzek, (unknown), (unknown), (unknown), (unknown), Mario Eisenberger, Alan W. Partin, Daniel W. Chan	24
10	Hybritech Total and Free Prostate-specific Antigen Assays Developed for the Beckman Coulter Access Automated Chemiluminescent Immunoassay System: A Multicenter Evaluation of Analytical Performance 2001 ·Clinical Chemistry ·Robert J. Laffin, Daniel W. Chan, Milenko J. Tanasijevic, G. Fischer, (unknown), (unknown), (unknown), Lori J. Sokoll, Debra J. Bruzek, (unknown), Janice M. Nelson, Kurtis R. Bray, (unknown), Kathleen G Loveland	22
11	COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCER 2000 ·The Journal of Urology ·Michael K. Brawer, Carol D Cheli, (unknown), (unknown), (unknown), Morton K. Schwartz, Debra J. Bruzek, (unknown), Lori J. Sokoll, Daniel W. Chan, (unknown), Alan W. Partin, W. Jeffrey Allard	7
12	COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCER 2000 ·The Journal of Urology ·Michael K. Brawer, Carol D Cheli, (unknown), (unknown), (unknown), Morton K. Schwartz, Debra J. Bruzek, (unknown), Lori J. Sokoll, Daniel W. Chan, (unknown), Alan W. Partin, W. Jeffrey Allard	117
13	Thrombomodulin: A New Marker for Placental Abruption 1999 ·Thrombosis and Haemostasis ·Daniel W. Chan, Debra J. Bruzek, Joshua A. Copel, Chaur‐Dong Hsu, Urania Magriples	13
14	Clinical Evaluation Comparing AxSYM<sup>®</sup> CA 15-3<sup>TM</sup>, IMx<sup>®</sup> CA 15-3 and Truquant<sup>®</sup> BR<sup>TM</sup> RIA 1998 ·Tumor Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Debra J. Bruzek, Jennifer Cox, (unknown), (unknown), Daniel W. Chan	8
15	INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELS 1998 ·The Journal of Urology ·Leslie R. Miller, Alan W. Partin, Daniel W. Chan, Debra J. Bruzek, Adrian S. Dobs, Jonathan I. Epstein, Patrick C. Walsh	143
16	Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer 1997 ·Urology ·Jürgen Pannek, Harry G. Rittenhouse, Cindy L. Evans, Judith A. Finlay, Debra J. Bruzek, Jennifer Cox, Daniel W. Chan, Eric N.P. Subong, Alan W. Partin	33
17	Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy breakdown → 1988 ·The Journal of Urology ·Joseph E. Oesterling, Daniel W. Chan, Jonathan I. Epstein, Allyn W. Kimball, Debra J. Bruzek, Robert C. Rock, Charles B. Brendler, Patrick C. Walsh	477
18	A new biomarker in monitoring breast cancer: CA 549. 1988 ·Journal of Clinical Oncology ·Roy Beveridge, David W. Chan, Debra J. Bruzek, Dorothy Damron, Kurtis R. Bray, Praveen Kumar Gaur, David S. Ettinger, Robert C. Rock, M. Salah Shurbaji, Francis P. Kuhajda	22
19	Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared. 1987 ·Clinical Chemistry ·Daniel W. Chan, Debra J. Bruzek, Joseph E. Oesterling, Robert C. Rock, Patrick C. Walsh	146
20	Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. 1987 ·Clinical Chemistry ·Robert C. Rock, (unknown), Debra J. Bruzek, (unknown), Joseph E. Oesterling, Patrick Walsh	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact